BCG vaccine Market by Type and Application- Global Industry Analysis and Forecast to 2023

2018-05-30 / 3800.00 / Pharma & Healthcare / 115 Pages

Description

Industry Outlook and Trend Analysis

The global BCG vaccine market was estimated at USD 17.12 million in 2012 and is anticipated to garner USD 26.63 million by 2023. BCG Vaccine is a vaccine essentially useful against tuberculosis. Tuberculosis is a severe infection, which damages the lungs and at times different parts of the body, for example, the joints, kidneys and bones. The bacille Calmette-Guérin (BCG) vaccine has existed for a long time and is a standout amongst the most broadly used of all conventional vaccines. The factors that drive the worldwide BCG vaccine market incorporate increment in prevalence of tuberculosis, particularly in creating and immature nations, and mechanical progression in the section of vaccine research. In addition, the expansion in government activities and spotlight on vaccination programs all around additionally help the market development. Nonetheless, symptoms of BCG vaccine and a worldwide lack of this immunization hinder the development of the market.

Type Outlook and Trend Analysis

Based on type the market is segmented into Therapy BCG and Immune BCG. Immune Intravesical Bacillus Calmette-Guerin (Immune BCG) is a debilitated nonpathogenic strain of Mycobacterium bovis that was first used as an antibody agent against tuberculosis. This vaccine permits achieving inertia stage by methods for control of the bacillus by serial advancement on culture medium. Therapy BCG vaccines upgrades Th1 immune responses in people. In cases as such, Th1 and Th2 cells are similarly coordinated. Treatment BCG inoculation are basically extended and compelled to the expiratory volume in 1 second and are additionally obliged to expiratory stream rate of around 25% to 75% at weeks 4, 8, and 12. In addition, treatment BCG vaccination is known for upgraded lung work and diminished pharmaceutical use in adults with direct to-serious asthma.

Application Outlook and Trend Analysis

Based on application the market is segmented into Clinics and Hospitals. Clinics play an essential part in spreading and vaccinating infants and children with BCG vaccines. For example, Tuberculosis is a basic general prosperity challenge in universally. In hospitals, the BCG vaccination is usually given to kids as it has been seemed to give extraordinary affirmation against the scattered kinds of TB in youths, including TB meningitis. However the affirmation gave against pneumonic TB in adults is to a great degree a main factor.

Regional Outlook and Trend Analysis

Geographically, the market is segmented into North America, Asia Pacific, Europe and Rest of the world. Europe is the dominating region of the BCG vaccines market. Asia Pacific is foreseen to develop significantly in the upcoming years.

Competitive Insights

The leading players in the market are China National Biotec Group Company Limited, InterVax Ltd, Merck & Co, Green Signal Bio Pharma Private Limited, Japan BCG Laboratory, Serum Institute of India Pvt Ltd and Statens Serum Institute. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The BCG Vaccine Market is segmented as follows-

By Type:


Immune BCG
Therapy BCG


By Application:


Clinics
Hospitals
Others


By Region


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2023`
What will be the industry market growth from 2015 to 2023`
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Rising prevalence of tuberculosis
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. BCG Vaccine Market, By Type
4.1. Introduction
4.2. Global BCG Vaccine Sales, Revenue and Market Share by Type (2014-2017)
4.2.1. Global BCG Vaccine Sales and Sales Share by Type (2014-2017)
4.2.2. Global BCG Vaccine Revenue and Revenue Share by Type (2014-2017)
4.3. BCG Vaccine Market Assessment and Forecast, By Type, 2014-2023
4.4. Immune BCG
4.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5. Therapy BCG
4.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5. BCG Vaccine Market, By Application
5.1. Introduction
5.2. Global BCG Vaccine Sales, Revenue and Market Share by Application (2014-2017)
5.2.1. Global BCG Vaccine Sales and Sales Share by Application (2014-2017)
5.2.2. Global BCG Vaccine Revenue and Revenue Share by Application (2014-2017)
5.3. The BCG Vaccine Market Assessment and Forecast, By Application, 2014-2023
5.4. Clinics
5.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.5. Hospitals
5.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.6. Others
5.6.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
6. BCG Vaccine Market, By Region
6.1. Introduction
6.2. BCG Vaccine Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.3. Global BCG Vaccine Sales, Revenue and Market Share by Regions
6.3.1. Global BCG Vaccine Sales by Regions (2014-2017)
6.3.2. Global BCG Vaccine Revenue by Regions (2014-2017)
6.4. North America
6.4.1. North America BCG Vaccine Sales and Growth Rate (2014-2017)
6.4.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.4.3. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.4.4. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.4.5. U.S.
6.4.5.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.4.5.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.4.6. Canada
6.4.6.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.4.6.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.4.7. Mexico
6.4.7.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.4.7.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.5. Europe
6.5.1. Europe BCG Vaccine Sales and Growth Rate (2014-2017)
6.5.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.5.3. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.5.4. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.5.5. Germany
6.5.5.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.5.5.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.5.6. France
6.5.6.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.5.6.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.5.7. UK
6.5.7.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.5.7.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.5.8. Italy
6.5.8.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.5.8.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.5.9. Spain
6.5.9.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.5.9.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.5.10. Rest of Europe
6.5.10.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.5.10.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific BCG Vaccine Sales and Growth Rate (2014-2017)
6.6.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.6.3. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.6.4. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.6.5. Japan
6.6.5.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.6.5.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.6.6. China
6.6.6.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.6.6.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.6.7. Australia
6.6.7.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.6.7.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.6.8. India
6.6.8.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.6.8.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.6.9. South Korea
6.6.9.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.6.9.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.6.10. Rest of Asia-Pacific
6.6.10.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.6.10.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.7. Rest of the World
6.7.1. Rest of the World BCG Vaccine Sales and Growth Rate (2014-2017)
6.7.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.7.3. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.7.4. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.7.5. Brazil
6.7.5.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.7.5.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.7.6. Turkey
6.7.6.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.7.6.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.7.7. Saudi Arabia
6.7.7.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.7.7.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.7.8. South Africa
6.7.8.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.7.8.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.7.9. United Arab Emirates
6.7.9.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.7.9.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
6.7.10. Others
6.7.10.1. Market Assessment and Forecast, By Type, 2014-2023($Million)
6.7.10.2. Market Assessment and Forecast, By Application, 2014-2023($Million)
7. Company Profiles
7.1. China National Biotec Group Company Limited
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. BCG Vaccine Sales, Revenue and Market Share
7.2. InterVax Ltd
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. BCG Vaccine Sales, Revenue and Market Share
7.3. Merck & Co
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. BCG Vaccine Sales, Revenue and Market Share
7.4. Green Signal Bio Pharma Private Limited
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. BCG Vaccine Sales, Revenue and Market Share
7.5. Japan BCG Laboratory
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. BCG Vaccine Sales, Revenue and Market Share
7.6. Serum Institute of India Pvt Ltd
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. BCG Vaccine Sales, Revenue and Market Share
7.7. Statens Serum Institute
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. BCG Vaccine Sales, Revenue and Market Share
8. Global BCG Vaccine Market Competition, by Manufacturer
8.1. Global BCG Vaccine Sales and Market Share by Manufacturer (2016-2017)
8.2. Global BCG Vaccine Revenue and Market Share by Manufacturer (2016-2017)
8.3. Top 5 BCG Vaccine Manufacturer Market Share
8.4. Market Competition Trend
List of Tables and Figures
*You can glance through the list of Tables and Figures when you view the sample copy of BCG Vaccine Market.


Table of Figures

*You can glance through the list of Tables and Figures when you view the sample copy of Biomass Energy Market.

Request Sample

* mark fields are compulsory